While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

This is especially true for people with exercise-induced asthma or EIB. For these people, their asthma symptoms are triggered ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody from UK ...

GSK (NYSE:GSK) has received Chinese regulatory approval for its drug Nucala, also known as mepolizumab, for the treatment of ...

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that targets ...

The total market size of eosinophilic esophagitis in 2023 was approximately USD 1.80 trillion in the 7MM, which is expected to grow during the forecast period (2020-2034). Among EU4 and the UK, ...

There is an urgent need for improved diagnostic tools and targeted therapies to address the gap in care for patients with ...

This leaves patients with non-eosinophilic or neutrophilic asthma without adequate options. ‘Can we truly help people with ...